Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Åke Svensson

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
Mathematical Biosciences|October 20, 2015
The influence of assumptions on generation time distributions in epidemic modelsÅke Svensson
Journal of Mathematical Biology|February 27, 2013
Who was the infector--probabilities in the presence of variability in latent and infectious timesÅke Svensson
Acta Dermato-Venereologica|September 4, 2018
Clinical Experience of Overnight Use of a Temperature-controlled Airflow Device in a Teenager with Severe Atopic DermatitisGrigorios Theodosiou, Åke Svensson
Acta Dermato-Venereologica|October 4, 2022
Increased Knowledge-based Care is Indicated for Patients with Atopic DermatitisMaria Bradley, Åke Svensson
Acta Dermato-Venereologica|June 1, 2017
Methotrexate-associated Sexual Dysfunction: Two Case ReportsGrigorios Theodosiou, Åke Svensson
Mathematical Biosciences|January 16, 2014
Estimation of the Malthusian parameter in an stochastic epidemic model using martingale methodsDavid Lindenstrand, Åke Svensson
Pediatric Dermatology|May 19, 2026
Dupilumab-Induced Psoriasis in an Adolescent With Severe Atopic Dermatitis: Successful Management With AbrocitinibGrigorios Theodosiou, Åke Svensson
The British Journal of Dermatology|February 4, 2025
Patient-reported outcome measures are urgently needed for patients with skin of colour who have atopic dermatitisLaura von Kobyletzki, Åke Svensson
Evidence-Based Medicine|April 5, 2015
Prenatal and postnatal exposure to parental smoking increases odds of allergic diseases during childhood and adolescenceLaura von Kobyletzki, Åke Svensson
Mycoses|October 5, 2011
Treatment of seborrhoeic dermatitis of the scalp with a topical solution of urea, lactic acid, and propylene glycol (K301): results of two double-blind, randomised, placebo-controlled studiesLennart Emtestam, Åke Svensson, Kjell Rensfeldt
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
Mathematical Biosciences|October 20, 2015
The influence of assumptions on generation time distributions in epidemic modelsÅke Svensson
Journal of Mathematical Biology|February 27, 2013
Who was the infector--probabilities in the presence of variability in latent and infectious timesÅke Svensson
Acta Dermato-Venereologica|September 4, 2018
Clinical Experience of Overnight Use of a Temperature-controlled Airflow Device in a Teenager with Severe Atopic DermatitisGrigorios Theodosiou, Åke Svensson
Acta Dermato-Venereologica|October 4, 2022
Increased Knowledge-based Care is Indicated for Patients with Atopic DermatitisMaria Bradley, Åke Svensson
Acta Dermato-Venereologica|June 1, 2017
Methotrexate-associated Sexual Dysfunction: Two Case ReportsGrigorios Theodosiou, Åke Svensson
Mathematical Biosciences|January 16, 2014
Estimation of the Malthusian parameter in an stochastic epidemic model using martingale methodsDavid Lindenstrand, Åke Svensson
Pediatric Dermatology|May 19, 2026
Dupilumab-Induced Psoriasis in an Adolescent With Severe Atopic Dermatitis: Successful Management With AbrocitinibGrigorios Theodosiou, Åke Svensson
The British Journal of Dermatology|February 4, 2025
Patient-reported outcome measures are urgently needed for patients with skin of colour who have atopic dermatitisLaura von Kobyletzki, Åke Svensson
Evidence-Based Medicine|April 5, 2015
Prenatal and postnatal exposure to parental smoking increases odds of allergic diseases during childhood and adolescenceLaura von Kobyletzki, Åke Svensson
Mycoses|October 5, 2011
Treatment of seborrhoeic dermatitis of the scalp with a topical solution of urea, lactic acid, and propylene glycol (K301): results of two double-blind, randomised, placebo-controlled studiesLennart Emtestam, Åke Svensson, Kjell Rensfeldt
Pageof 10